ACUTA CAPITAL PARTNERS, LLC
Holdings as of 2026-06-30, filed 2026-08-14
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 45 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
23
Value reported by manager
$143.5M
Sum of our stored positions
$143.5M
should match the line above
Disclosure lag
45 d
quarter end to filing
Top 5 concentration
54.3%
of the positions shown
New positions
0
vs previous quarter
Exited
0
vs previous quarter
Option positions
0
puts and calls
Positions
23 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | $27.7M | 82,796 | — | 74006W207 |
| WHITEHAWK THERAPEUTICS INC | COM | $21.5M | 4,685,912 | — | 00032Q104 |
| TANGO THERAPEUTICS INC | COM | $12.2M | 390,949 | — | 87583X109 |
| SUTRO BIOPHARMA INC | COM | $9M | 270,251 | — | 869367201 |
| ARRIVENT BIOPHARMA INC | COM | $7.6M | 218,694 | — | 04272N102 |
| 4D MOLECULAR THERAPEUTICS INC | COM | $6.8M | 507,801 | — | 35104E100 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $6.5M | 92,745 | — | 10919W405 |
| OCULAR THERAPEUTIX INC | COM | $5.2M | 532,481 | — | 67576A100 |
| ERASCA INC | COM | $4.9M | 265,199 | — | 29479A108 |
| SURROZEN INC | COM NEW | $4.5M | 173,395 | — | 86889P208 |
| ARGEN SE - ADR | SPONSORED ADR | $4.4M | 4,705 | — | 04016X101 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS ORD A | $4.2M | 215,652 | — | 61559X104 |
| DESIGN THERAPEUTICS INC | COM | $4.1M | 282,564 | — | 25056L103 |
| MINERVA NEUROSCIENCES | COM NEW | $3.9M | 709,500 | — | 603380205 |
| TAYSHA GENE THERAPIES INC | COM SHS | $3.8M | 561,808 | — | 877619106 |
| AVALYN PHARMA INC | COM SHS | $3.8M | 115,000 | — | 05348Y105 |
| AVALO THERAPEUTICS INC | COM NEW | $3.4M | 186,308 | — | 05338F306 |
| AMYLYX PHARMACEUTICALS INC | COM | $3M | 168,115 | — | 03237H101 |
| ARTIVA BIOTHERAPEUTICS INC | COM | $2.5M | 260,416 | — | 04317A107 |
| COMPASS THERAPEUTICS INC | COM | $1.3M | 595,213 | — | 20454B104 |
| UNITED THERAPEUTICS CORP | COM | $1.2M | 2,224 | — | 91307C102 |
| CONTINEUM THERAPEUTICS INC-A | CL A | $1M | 63,095 | — | 21217B100 |
| LB PHARMACEUTICALS INC | COM SHS | $938.6K | 28,919 | — | 50180M108 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-14